Physicians

Resources For Physicians

• Initiating Buprenorphine Treatment in the Emergency Department | National Institute on Drug Abuse (NIDA) (nih.gov)
• About the Addiction Medicine Subspecialty | National Institute on Drug Abuse (NIDA) (nih.gov)
• Science to Medicine: A CME/CE Activity | National Institute on Drug Abuse (NIDA) (nih.gov)
  This module provides basic information about screening and management of opioid use disorder
• Screening and Assessment Tools Chart | National Institute on Drug Abuse (NIDA) (nih.gov)
• Disposal of Unused Medicines: What You Should Know | FDA
• National Prescription Drug Take Back Day (usdoj.gov)
• Opioid Crisis and Pain Management | National Institute on Drug Abuse (NIDA) (nih.gov)
• Oral Health and Sublingual Buprenorphine
• Become a Buprenorphine Waivered Practitioner | SAMHSA
• Naloxone for Opioid Overdose: Life-Saving Science | National Institute on Drug Abuse (NIDA) (nih.gov)
• FSSA: DMHA: For Addiction Providers (in.gov)
• Clinical Resources (asam.org) ASAM criteria, assessment tools, etc.

Clinical Guidelines

• The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update
• COVID-19 (asam.org)
• The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
• The ASAM Appropriate Use of Drug Testing Consensus Document
• Standards and Performance (asam.org)